Drug intelligence / Profile preview

Clotic

Development stage
Approved
Lead developer
Laboratorios Salvat
Modality
Small Molecules
Administration
Otic, Topical
01

Overview

Clotic is a branded, preservative-free 1% clotrimazole otic solution formulated in sterile single-dose vials for the treatment of fungal otitis externa (otomycosis), specifically infections caused by Aspergillus and Candida species in patients with an intact tympanic membrane.[1][2][5][6] As an azole antifungal, clotrimazole inhibits cytochrome P450–dependent enzymes involved in ergosterol synthesis, disrupting fungal cell membrane integrity and leading to growth inhibition and cell death.[1][3] Developed by Laboratorios Salvat/Salvat Pharmaceutical Group and manufactured at its Pharmaloop facility using blow-fill-seal technology, Clotic is the first otic product with clinical evidence and specific regulatory approval for otomycosis and is administered as ear drops, typically twice daily for 14 days.[1][2][3][4][6][7]

Brand names
Clotic
Other names
clotrimazole otic solution 1%
02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on Clotic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clotic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call